This report on the global veterinary molecular diagnostics market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research represents a bulk of TMR’s research efforts along with the information collected from telephonic interviews and interactions via e-mails. Secondary research involves study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates of each segment of the global veterinary molecular diagnostics market have been determined after thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. The report also provides insights into key trends in the veterinary molecular diagnostics market such as shift in distribution channels, changes in consumer behavior, pet humanization and premiumization, and growing mixture of local and multinational players. Key market indicators influencing the global veterinary molecular diagnostics market taken into consideration include cost constraints and regulatory landscape. The report also includes market attractiveness analysis of major segments, which provides thorough analysis of the overall competition scenario in the global veterinary molecular diagnostics market. The report also includes Porter’s five forces analysis of the global veterinary molecular diagnostics market.
Request Brochure for Report –
Global Veterinary Molecular Diagnostics market Witness Most Promising Rise in Demand
The global animal health care sector continues to expand at a rapid pace. In developed countries, the sector is driven by improved diagnostic and medical capabilities for companion animals. Technologically advanced diagnostic assays and techniques (such as RTPCR) are experiencing more demand than the conventional diagnosis products. Increased longevity of pet animals led by improvement in diagnostics, greater focus on wellness and prevention by veterinarians, and enhanced nutrition have expanded the scope for use of veterinary diagnostic services and medications. The number of pet ownerships in developed as well as emerging markets is increasing. As a result, expenditure on companion animals is rising globally.
The market in the region is projected to expand at a significant CAGR from 2017 to 2025. High adoption and usage of superior-quality diagnostics and treatments in the region is one of the major factors driving the veterinary molecular diagnostics market in Europe. This can be attributed to increase in the number of diagnostic laboratories, government funding for veterinary health care activities, and rise in awareness about veterinary molecular diagnostics in the region. Asia Pacific is a rapidly expanding market across the world. High adoption of veterinary diagnostics, drugs, vaccines, and medicated feed additives for the well-being of rapidly increasing population of livestock animals in the region makes Asia Pacific one of the most lucrative markets for veterinary molecular diagnostics.
Request for Analysis of COVID19 Impact on Veterinary Molecular Diagnostics Market –
Rise in the expenditure on diagnostics, therapeutics, feed additives, and other supplies for companion animals; increase in the number of pet owners and growing urbanization are likely to provide significant opportunities to the veterinary molecular diagnostics market in developing countries during the forecast period. Sophisticated molecular diagnostic instruments and assays are well-recognized and validated for proper testing. However, high costs associated with these systems and assays and lack of skilled technicians pose a significant restraint for the market.
Key Players of Veterinary Molecular Diagnostics Market Report:
Key companies profiled in the report include IDEXX Laboratories, Inc., VCA, Inc., Thermo Fisher Scientific, Inc., Novacyt Group, QIAGEN N.V., Biomedica Medizinprodukte GmbH & Co KG, HealthGene Corporation, and Bioneer. These players are adopting organic and inorganic growth strategies to expand their product offerings; enhance their geographical reach; widen their customer base; and gain market share. For example, in March 2015, VCA acquired the molecular diagnostics division of Abaxis Veterinary Reference Laboratory (AVRL).
Buy Veterinary Molecular Diagnostics Market Report –
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453